HBQ Stock Overview
Engages in the production of health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Europe, Japan, Asia, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 0.22 |
| 52 Week High | NOK 0.30 |
| 52 Week Low | NOK 0.074 |
| Beta | 0.57 |
| 1 Month Change | 46.49% |
| 3 Month Change | -17.98% |
| 1 Year Change | 22.35% |
| 3 Year Change | -30.48% |
| 5 Year Change | -73.36% |
| Change since IPO | -14.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| HBQ | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 49.5% | -0.9% | 1.4% |
| 1Y | 22.3% | -12.8% | 13.8% |
Return vs Industry: HBQ exceeded the German Biotechs industry which returned -11% over the past year.
Return vs Market: HBQ exceeded the German Market which returned 13.8% over the past year.
Price Volatility
| HBQ volatility | |
|---|---|
| HBQ Average Weekly Movement | 18.9% |
| Biotechs Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: HBQ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: HBQ's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 75 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA engages in the production of health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for weight management, and metabolism; CalGo, a calcium collagen complex for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was founded in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| HBQ fundamental statistics | |
|---|---|
| Market cap | €75.96m |
| Earnings (TTM) | -€10.82m |
| Revenue (TTM) | €22.93m |
3.3x
P/S Ratio-7.0x
P/E RatioIs HBQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBQ income statement (TTM) | |
|---|---|
| Revenue | NOK 265.54m |
| Cost of Revenue | NOK 189.81m |
| Gross Profit | NOK 75.73m |
| Other Expenses | NOK 201.03m |
| Earnings | -NOK 125.30m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 16, 2025
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 28.52% |
| Net Profit Margin | -47.19% |
| Debt/Equity Ratio | 123.2% |
How did HBQ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/13 05:58 |
| End of Day Share Price | 2025/05/13 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hofseth BioCare ASA is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonas Peciulis | Norne Securities AS |
| Henning Steffenrud | Swedbank Norway |